Chang Yi Wang (王長怡)
Born (1951-12-19) December 19, 1951
Taipei; Taiwan
Alma mater
Known for
SpouseNean Hu
ChildrenMei Mei Hu
Scientific career
Institutions
Doctoral advisorHenry Kunkel
Other academic advisors

Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡; pinyin: Wángzhǎngyí; IPA: [tʃɒ̌ŋ jí wɒ́ŋ]) is the founder of United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia (including United Biomedical Asia).

Early life and education

Wang was born in Taiwan in 1951.[1] Her father was a member of the National Assembly. She was inspired to go into science by the example of physicist Chien-Shiung Wu who disproved the ‘conservation of parity’ theory in 1957.[2] She graduated with honors from the National Taiwan University in 1973, majoring in organic chemistry.

She was the first Asian woman on the Rockefeller University graduate programme and achieved her Ph.D. degree in 1979 with a dual specialization in Biochemistry and Immunology. She was mentored by Bruce Merrifield, Henry Kunkel, Gerald Edelman and Ralph Steinman.[2] She then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator, and head of the molecular immunology laboratory.[3]

Career in immunology and entrepreneurship in the biomedical industry

In 1985, Wang and her husband Nean Hu founded United Biomedical, Inc. in New York - the company’s main focus is on medicine and vaccine development.[4] She founded United Biomedical, Inc. Asia in Taiwan in 1998.[1] She later founded United Biopharma and UBI Pharma in 2013 and 2014 respectively.[5][6]

The companies later created testing for HIV and Hepatitis C, and carried out research on a vaccine for HIV.[2]

Wang is the author of more than 120 peer-reviewed scientific publications and by 2019, she was the inventor of more than 80 patents.[7][8]

Awards

In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Wang with the Inventor of the Year Award.[9]

In 2009, the Bill and Melinda Gates Foundation awarded Grand Challenges Exploration Grants to Wang for the Synthetic Peptides to Inhibit HIV Entry program.[10]

In 2018, the Brain Mapping Foundation presented Wang with the Pioneer in Technology Award.[11]

In 2021, Wang was part of a court case which concerned the ownership of UBI, in particular, possible breach of contractual agreements and misuse of authority positions.[12][13]

Family

Wang’s daughter Mei Mei Hu is the co-founder and CEO of Vaxxinity (originally named Covaxx), a subsidiary of UBI;[14] the company originally focused on possible vaccines for Alzheimer’s and animal health[15] but shifted to working on a vaccine for COVID-19. The company helped to develop vaccine candidate UB-612.[16][17]

Professional and honorary affiliations

References

  1. 1 2 "王長怡×王瑞瑜 突破台灣生技盲點｜天下雜誌". 天下雜誌 (in Chinese (Taiwan)). Retrieved October 6, 2019.
  2. 1 2 3 Wired UK website, article dated June 24, 2019
  3. ↑ "A vaccine for Alzheimer's is on the verge of becoming a reality". Wired UK. Retrieved October 11, 2019.
  4. ↑ "人物側寫－8萬美元起家 王長怡 締造生技業奇蹟 - 財經要聞". 中時電子報 (in Chinese). Retrieved October 6, 2019.
  5. ↑ "About United BioPharma". www.unitedbiopharma.com. Retrieved October 11, 2019.
  6. ↑ "UBI Pharma Company Overview". www.ubi-pharma.com. Retrieved October 11, 2019.
  7. ↑ "Publication". www.unitedbiomedical.com. Archived from the original on October 6, 2019. Retrieved October 7, 2019.
  8. ↑ Justia Patents website, profile page
  9. ↑ "United Biomedical, Inc. CEO Dr. Chang Yi Wang named Inventor of the Year 2007 by New York Intellectual Property Law Association". NewsRx. June 17, 2007. Archived from the original on September 28, 2011. Retrieved August 5, 2011.
  10. ↑ "Global Grand Challenges". gcgh.grandchallenges.org. Retrieved October 11, 2019.
  11. ↑ "Pioneer in Technology Award". www.worldbrainmapping.org. Retrieved October 7, 2019.
  12. ↑ Trellis Law website, Suffocilk County Supreme Courts page (Dr Chang Yi Wang -v- United Biomedical Inc), retrieved 2023-08-28
  13. ↑ UniCourt website, retrieved 2023-08-28
  14. ↑ Clinical Trials Arena website, article dated May 19, 2021
  15. ↑ Business Wire website, article dated November 25, 2020
  16. ↑ Liao G (June 27, 2021). "Taiwan News website, Taiwan's second domestic COVID vaccine's midterm performance in phase II trials inferior to local competitor: experts". Taiwan News. Retrieved July 8, 2021.
  17. ↑ PR Newswire website, article dated July 15, 2020
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.